+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fundamental study on a low molecular immunomodifier ubenimex



Fundamental study on a low molecular immunomodifier ubenimex



Takeuchi, T , K Nitta And N Tanaka (Ed ) Gann Monograph on Cancer Research, No 36 Antitumor Natural Products: Basic And Clinical Research Xviii+206p Japanese Cancer Association: Tokyo, Japan; Taylor And Francis Ltd : London, England, Uk; Bristol, Pennsylvania, Usa Illus 147-156




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031521205

Download citation: RISBibTeXText


Related references

Bestatin (Ubenimex)--a low molecular immunomodifier. Papers from a workshop at the 16th International Congress of Chemotherapy. Jerusalem, June 11-16, 1989. Proceedings. Acta Oncologica 29(6): 793-831, 1990

Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT. Transplantation Proceedings 24(6): 3047-3048, 1992

Effect of forphenicinol a small molecular immunomodifier on growth of a syngeneic guinea pig hepatoma and a study of its mechanisms. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 659, 1986

Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier. Tohoku Journal of Experimental Medicine 146(4): 419-427, 1985

Imbalance of T cell subsets in cancer patients and its modification with bestatin, a small molecular immunomodifier. Tohoku Journal of Experimental Medicine 147(2): 125-133, 1985

Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4. Journal of Biological Response Modifiers 6(1): 35-43, 1987

Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms. Journal of Antibiotics 40(4): 547-554, 1987

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections. Journal of Antibiotics 35(8): 1049-1054, 1982

Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Cancer Treatment Reports 69(3): 285-291, 1985

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755. Journal of Antibiotics 39(4): 564-568, 1986

Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 20(9): 1187-1194, 1993

A pilot study of a long-term immunomodulatory treatment with ubenimex for patients with HAM/TSP. Journal of Neuroimmunology 90(1): 97, Sept 1, 1998

Autoradiographic study of tissue distribution of [3H]ubenimex in IMC carcinoma-bearing mice. International Journal of Immunopharmacology 12(7): 755-760, 1990

The vertebrate eye lens a useful system for the study of fundamental biological processes on a molecular level. Science (Washington D C) 197(4299): 127-138, 1977

Molecular genetic approaches to the study of the HLA system: New potentials in fundamental and applied studies. Byulleten' Eksperimental'noi Biologii i Meditsiny 118(10): 436-439, 1994